Group 1 - The core point of the article is that Foshan Plastics Technology has received approval from the Shenzhen Stock Exchange for its acquisition of 100% of Jinyi Co., Ltd. through a combination of issuing shares and cash payment, which is expected to enhance its competitiveness in the lithium battery separator market [1] - Jinyi Co., Ltd. specializes in the research, production, and sales of lithium battery separators, holding an 18% market share in China's wet-process separator sector, ranking second in the industry according to GGII [1] - Foshan Plastics Technology, as an important platform under Guangdong Guangxin Holdings Group, focuses on the development and production of polymer functional films and composite materials for various industries, including new energy and electrical engineering [1] Group 2 - The global trend towards energy conservation and emission reduction is driving continuous growth in the lithium-ion battery market, leading to an increase in separator shipments [2] - GGII data indicates that by the first half of 2025, China's lithium battery separator shipments are expected to reach 13.6 billion square meters, a 49% year-on-year increase, with wet-process separators accounting for over 80% of total shipments [2] - Jinyi Co., Ltd. reported an operating income of 326.08 million yuan and a net profit of 25.51 million yuan for the period from January to October 2025, indicating strong financial performance [2] - The implementation of this acquisition is anticipated to enhance the company's core competitiveness and expand its product offerings in the new energy sector, positioning it as a leading enterprise in the polymer functional film materials industry [2]

Core Viewpoint - The Shenzhen Stock Exchange's M&A Review Committee approved Foshan Fospower Technology Group Co., Ltd.'s asset purchase through share issuance, meeting restructuring conditions and disclosure requirements [1] Group 1: Transaction Details - The transaction involves issuing shares and cash to acquire 100% of Jinyi Co., Ltd. from 102 counterparties, including Yuan Haichao and Huahao Century [5] - The total transaction price for the acquired assets is set at RMB 508 million, with RMB 40 million paid in cash and RMB 468 million through share issuance [6] - The share issuance price is determined at RMB 3.84 per share, which is not less than 80% of the average trading price over the last 20 trading days [8] Group 2: Financial Assessment - The valuation report indicates that the equity value of the target company is RMB 508.37 million, representing a 20.78% increase over the book value [6][7] - The transaction price reflects a premium based on the assessed value, with the increase in value calculated at RMB 87.48 million [6][7] Group 3: Market Context - The target company specializes in the research, production, and sales of lithium battery separators, with recent market conditions showing a tightening supply-demand balance due to increased production capacity and reduced demand growth [10] - The company experienced a decline in performance due to price fluctuations in the lithium battery separator market, prompting a withdrawal of its IPO application [10] Group 4: Strategic Implications - The transaction is expected to enable the company to enter the lithium battery separator sector, enhancing its growth potential in the renewable energy space and improving shareholder returns [11]

Group 1 - Jinggong Technology signed a sales contract with Hubei Yuchuang worth 729 million yuan, accounting for 42.16% of the company's audited revenue for 2024 [1] - Heshun Electric is expected to win a bid for a State Grid procurement project worth 107 million yuan, representing 24.97% of the company's 2024 revenue [2] - Yongmaotai plans to invest approximately 400 million yuan in a new intelligent manufacturing project for magnesium-aluminum alloy materials [3] Group 2 - Longi Green Energy announced the termination of its plan to issue global depositary receipts abroad, stating it will not significantly impact its operations [4] - Bai Ao Intelligent is expected to win bids for projects totaling 27.5 million yuan [5] - Lian Biological is planning a change of control and asset purchase, leading to a temporary suspension of its stock [6] Group 3 - Bo Rui Communication intends to acquire 51% of Meijing Technology for 66.49 million yuan [7] - Huitai Medical plans to repurchase shares worth 200 to 250 million yuan for employee stock ownership plans [8] - Yifang Biological is planning to issue H-shares and apply for listing on the Hong Kong Stock Exchange [9] Group 4 - Jiuqiang Biological's shareholders signed an agreement for the transfer of 5% of the company's shares to China National Pharmaceutical Investment [11] - Songcheng Performing Arts plans to repurchase shares worth 100 to 200 million yuan for capital reduction [12] - Zhonghong Medical's subsidiary is expected to be selected for a centralized procurement project in Jiangxi Province [13] Group 5 - Xingfu Electronics plans to invest 480 million yuan in a new electronic-grade phosphoric acid project [14] - Jiaao Environmental Protection's stock will be subject to risk warnings due to an administrative penalty [15] - ST Nuotai received a drug registration certificate for a new injection [16] Group 6 - Haimo Technology plans to sell its controlling subsidiary, Xian Sitian Instrument, for 370 million yuan [17] - Jingce Electronics signed multiple sales contracts with a single customer totaling 433 million yuan [18] - Donghua Testing's controlling shareholder plans to reduce its stake by up to 1.99% [19][20] Group 7 - Xingqi Eye Medicine completed the first subject enrollment for a Phase II clinical trial of its eye drop product [21] - Kute Intelligent's controlling shareholder plans to reduce its stake by up to 2% [22] - Dongcheng Pharmaceutical's subsidiary received approval for a new specification of a heparin sodium injection [23] Group 8 - Zhaoyi Innovation is in the process of issuing H-shares and has received regulatory approval [24] - Aokang International's shareholder plans to reduce its stake by up to 3% [25] - Jiamei Packaging's controlling shareholder is planning a change of control, leading to a temporary stock suspension [26] Group 9 - ST Kevin's stock will have its risk warning lifted and will resume trading [27] - Zaiseng Technology's controlling shareholder plans to transfer 6.04% of the company's shares [28] - Lide New Energy's shareholder plans to reduce its stake by up to 1% [29] Group 10 - Srypu terminated its plan to acquire shares and will resume trading [30] - Longjiang Transportation's subsidiary plans to invest 2.679 billion yuan in a graphite mining project [31] - Haowei Group's controlling shareholder has not reduced its stake and has terminated the reduction plan [32] Group 11 - Huilun Crystal received an administrative penalty notice for information disclosure violations [33] - Haiguang Information terminated a major asset restructuring plan [34] - Zhongke Shuguang announced a cash dividend plan [35] Group 12 - Fushuo Technology's share purchase plan was approved by the Shenzhen Stock Exchange [36] - Dongbai Group's shareholder reduced its stake by 25.95 million shares [38]

智通财经APP讯，佛塑科技(000973.SZ)公告，公司拟通过发行股份及支付现金的方式向袁海朝、北京华 浩世纪投资有限公司等102名交易对方购买其合计所持有的河北金力新能源科技股份有限公司100%股 份，并向公司控股股东广东省广新控股集团有限公司发行股份募集配套资金。 深圳证券交易所并购重组审核委员会于2025年12月9日召开2025年第13次并购重组审核委员会审议会 议，对本次交易的申请进行了审议。根据深圳证券交易所并购重组审核委员会发布的《深圳证券交易所 并购重组审核委员会2025年第13次审议会议结果公告》，本次会议的审议结果为：本次交易符合重组条 件和信息披露要求。 ...

深圳证券交易所并购重组审核委员会于2025年12月9日召开2025年第13次并购重组审核委员会审议会 议，对本次交易的申请进行了审议。根据深圳证券交易所并购重组审核委员会发布的《深圳证券交易所 并购重组审核委员会2025年第13次审议会议结果公告》，本次会议的审议结果为：本次交易符合重组条 件和信息披露要求。 智通财经APP讯，佛塑科技(000973.SZ)公告，公司拟通过发行股份及支付现金的方式向袁海朝、北京华 浩世纪投资有限公司等102名交易对方购买其合计所持有的河北金力新能源科技股份有限公司100%股 份，并向公司控股股东广东省广新控股集团有限公司发行股份募集配套资金。 ...

人民财讯12月9日电，佛塑科技（000973）12月9日公告，公司拟通过发行股份及支付现金的方式向袁海 朝等102名交易对方购买其合计所持有的河北金力新能源科技股份有限公司100%股份，并向控股股东广 东省广新控股集团有限公司发行股份募集配套资金。深交所并购重组审核委员会于2025年12月9日召开 2025年第13次并购重组审核委员会审议会议，本次会议的审议结果为，本次交易符合重组条件和信息披 露要求。 ...

佛塑科技公告，深圳证券交易所并购重组审核委员会于2025年12月9日召开2025年第13次审议会议，对 公司拟通过发行股份及支付现金购买河北金力新能源科技股份有限公司100%股份并募集配套资金的交 易申请进行了审议。审议结果为本次交易符合重组条件和信息披露要求。该交易尚需取得中国证券监督 管理委员会同意注册的批复后方可实施，相关事项能否取得批复及最终取得时间存在不确定性。 ...

证券代码：000973 证券简称：佛塑科技 公告编号：2025-83 佛山佛塑科技集团股份有限公司 本次交易尚需取得中国证券监督管理委员会同意注册的批复后方可实施。本次 交易相关事项能否取得同意注册的批复以及最终取得的时间均存在不确定性。公司 将继续推进本次交易的相关工作，并严格按照有关法律法规的要求履行信息披露义 务。《中国证券报》《证券时报》和巨潮资讯网（www.cninfo.com.cn）为公司指定 的信息披露媒体，所有信息均以在公司指定信息披露媒体刊登的公告为准。敬请广 大投资者关注后续公告，注意投资风险。 1 特此公告。 佛山佛塑科技集团股份有限公司 董 事 会 二〇二五年十二月十日 2 关于公司发行股份及支付现金购买资产并募集配套资金 暨关联交易事项获深圳证券交易所并购重组审核委员会 审核通过的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏。 佛山佛塑科技集团股份有限公司（以下简称公司）拟通过发行股份及支付现金 的方式向袁海朝、北京华浩世纪投资有限公司等 102 名交易对方购买其合计所持有 的河北金力新能源科技股份有限公司 100%股份，并向 ...

佛塑科技12月1日公告：拟以50.8亿元总价收购金力股份全部股权，其中46.8亿元定向发行股份、4亿元 现金支付。标的公司专注湿法基膜及涂覆隔膜，2024年国内湿法隔膜市占率18%，排名行业第二，已建 及在建产线共46条，七成以上为2023年后投产的先进大宽幅设备，具备5μm及以下超薄高强度隔膜的稳 定量产能力，成本与性能领先。下游新能源车、储能需求高增，2025年上半年中国锂电池隔膜出货量 136亿平，同比增长49%，湿法隔膜112亿平，同比增长58%，占比超80%，行业价格止跌回稳。金力股 份2025年1—10月实现营业收入32.6亿元，净利润2.55亿元（未经审计），规模效应已现。GGII预计 2025—2027年中国湿法隔膜需求年复合增速约19%，2027年达295亿平，高端产能仍稀缺。交易完成 后，金力股份可借助上市平台拓宽融资渠道，降低财务费用；佛塑科技则快速切入新赛道，分享锂电产 业长周期红利，并通过资源整合进一步放大规模优势，巩固在高端隔膜市场的领先地位。 ...

Group 1 - The company held its 34th meeting of the 11th Board of Directors on December 5, 2025, with all 7 participating directors present, complying with relevant laws and regulations [1][2] - The Board approved the proposal to amend the company's investment management system, with details published on the official information disclosure platform [1] - The Board also approved the performance evaluation results and bonus settlement report for the leadership team for the year 2024, which had been reviewed by the Compensation and Assessment Committee [3][4] - Additionally, the Board approved the report on the total salary settlement for the year 2024, with unanimous support from all participating directors [5]